A Kahan

Summary

Country: France

Publications

  1. pmc Body mass index influences the response to infliximab in ankylosing spondylitis
    Sebastien Ottaviani
    Rheumatology Department, AP HP, Paris Diderot, Sorbonne Paris Cité University, Bichat Claude Bernard Hospital, 46 rue Henri Huchard, Paris, 75018, France
    Arthritis Res Ther 14:R115. 2012
  2. pmc Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity
    Vanina Jodon de Villeroché
    INSERM U781, Paris Descartes University, Necker Hospital, 149 rue de Sevres, 75015 Paris, France
    Arthritis Res Ther 12:R27. 2010
  3. ncbi request reprint [Primary scleroderma myocardial disease]
    Andre Kahan
    Rhumatologie A, Hopital Cochin, AP HP, 27 rue du Faubourg Saint Jacques, 75014 Paris, Universite Paris Descartes, France
    Bull Acad Natl Med 195:69-76; discussion 76-7. 2011
  4. ncbi request reprint Primary myocardial involvement in systemic sclerosis
    A Kahan
    Paris 5 René Descartes University, Department of Rheumatology A, Cochin Hospital, AP HP, Paris, France
    Rheumatology (Oxford) 45:iv14-7. 2006
  5. doi request reprint Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial
    Andre Kahan
    University of Paris Descartes, and Cochin Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:524-33. 2009
  6. doi request reprint Cardiac complications of systemic sclerosis
    A Kahan
    Department of Rheumatology A, Cochin Hospital, University of Paris Descartes, AP HP, Paris, France
    Rheumatology (Oxford) 48:iii45-8. 2009
  7. doi request reprint Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis
    P Dieude
    Universite Paris 7, and Hôpital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:225-33. 2009
  8. doi request reprint BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4
    P Dieude
    Universite Paris 7 Denis Diderot, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    Arthritis Rheum 60:3447-54. 2009
  9. doi request reprint High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis
    Y Allanore
    Rene Descartes University, Cochin Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 58:284-91. 2008
  10. doi request reprint STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
    P Dieude
    Université Paris 7 and Service de Rhumatologie, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:2472-9. 2009

Detail Information

Publications69

  1. pmc Body mass index influences the response to infliximab in ankylosing spondylitis
    Sebastien Ottaviani
    Rheumatology Department, AP HP, Paris Diderot, Sorbonne Paris Cité University, Bichat Claude Bernard Hospital, 46 rue Henri Huchard, Paris, 75018, France
    Arthritis Res Ther 14:R115. 2012
    ..The aim of this study was to determine whether body mass index (BMI) affects response to infliximab (IFX) in ankylosing spondylitis (AS) patients...
  2. pmc Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity
    Vanina Jodon de Villeroché
    INSERM U781, Paris Descartes University, Necker Hospital, 149 rue de Sevres, 75015 Paris, France
    Arthritis Res Ther 12:R27. 2010
    ..Contradictory results have been published regarding circulating endothelial progenitor cells (EPCs) in RA. We herein investigated late outgrowth EPC sub-population using recent recommendations in patients with RA and healthy controls...
  3. ncbi request reprint [Primary scleroderma myocardial disease]
    Andre Kahan
    Rhumatologie A, Hopital Cochin, AP HP, 27 rue du Faubourg Saint Jacques, 75014 Paris, Universite Paris Descartes, France
    Bull Acad Natl Med 195:69-76; discussion 76-7. 2011
    ....
  4. ncbi request reprint Primary myocardial involvement in systemic sclerosis
    A Kahan
    Paris 5 René Descartes University, Department of Rheumatology A, Cochin Hospital, AP HP, Paris, France
    Rheumatology (Oxford) 45:iv14-7. 2006
    ..Vasodilators, such as calcium channel blockers and angiotensin converting enzyme inhibitors, improve both myocardial perfusion and function abnormalities...
  5. doi request reprint Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial
    Andre Kahan
    University of Paris Descartes, and Cochin Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:524-33. 2009
    ..To assess the long-term effects of chondroitins 4 and 6 sulfate (CS) on the radiographic progression of, and symptom changes associated with, knee osteoarthritis (OA)...
  6. doi request reprint Cardiac complications of systemic sclerosis
    A Kahan
    Department of Rheumatology A, Cochin Hospital, University of Paris Descartes, AP HP, Paris, France
    Rheumatology (Oxford) 48:iii45-8. 2009
    ..However, it remains to be seen if early intervention can limit the progression of these life-threatening complications...
  7. doi request reprint Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis
    P Dieude
    Universite Paris 7, and Hôpital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:225-33. 2009
    ..The aim of this study was to determine whether the IRF5 rs2004640 single-nucleotide polymorphism is associated with SSc...
  8. doi request reprint BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4
    P Dieude
    Universite Paris 7 Denis Diderot, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris AP HP, Paris, France
    Arthritis Rheum 60:3447-54. 2009
    ....
  9. doi request reprint High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis
    Y Allanore
    Rene Descartes University, Cochin Hospital, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 58:284-91. 2008
    ..To evaluate predictors of pulmonary arterial hypertension (PAH) in a prospective cohort of patients with systemic sclerosis (SSc)...
  10. doi request reprint STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis
    P Dieude
    Université Paris 7 and Service de Rhumatologie, Hopital Bichat Claude Bernard, Assistance Publique Hopitaux de Paris, Paris, France
    Arthritis Rheum 60:2472-9. 2009
    ..The aim of this study was to determine whether the STAT4 rs7574865 single-nucleotide polymorphism is associated with SSc, and whether it interacts with IRF5...
  11. doi request reprint Association of hypoxia-inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population
    J Wipff
    Rene Descartes University, Department of Rheumatology A, Cochin Hospital, Paris
    Scand J Rheumatol 38:291-4. 2009
    ..The aim of this study was to determine whether polymorphisms of the hypoxia-inducible factor 1A gene (HIF1A) affects susceptibility to SSc in a large French European Caucasian population...
  12. ncbi request reprint Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin
    J Wipff
    Department of Rheumatology A, Paris Descartes University, Medical Faculty, Cochin Hospital, Paris, France
    Rheumatology (Oxford) 47:972-5. 2008
    ..The aim of this study was to investigate, in a cross-sectional study, sENG levels together with other serum vascular markers...
  13. doi request reprint Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions
    J Avouac
    Université Paris Descartes and Hôpital Cochin, Assistance Publique Hopitaux de Paris, Paris, and INSERM U781, Hopital Necker, Paris, France
    Arthritis Rheum 58:3550-61. 2008
    ..To assess angiogenesis and explore the expression and regulation of vascular endothelial growth factor (VEGF), VEGF receptor 1 (VEGFR-1), and VEGFR-2, the leading mediators of angiogenesis, in SSc patients and controls...
  14. doi request reprint Myopathies related to systemic sclerosis: a case-control study of associated clinical and immunological features
    B Ranque
    Department of Internal Medicine, French National Reference Center for Systemic Sclerosis and Necrotizing Vasculitides, Cochin Hospital, Faculty of Medicine, Paris Descartes University, the Public Assistance Hospitals of Paris AH HP, France
    Scand J Rheumatol 39:498-505. 2010
    ..Little is known about systemic sclerosis (SSc)-related myopathy. We aimed to compare the clinical and immunological features of SSc patients with or without associated myopathy...
  15. doi request reprint The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis
    P Dieude
    Universite Paris 7, Paris, France
    Arthritis Rheum 58:2183-8. 2008
    ..We then conducted a meta-analysis of the most recent studies of SSc in order to verify the association or lack of association between the PTPN22 1858C>T variant and SSc...
  16. doi request reprint Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population
    J Wipff
    Universite Paris Descartes, INSERM U781, Hopital Necker, and Hôpital Cochin, Paris, France
    Arthritis Rheum 62:3093-100. 2010
    ..We undertook this study to determine whether KCNA5 polymorphisms confer susceptibility to SSc and its vascular phenotype, including PAH...
  17. doi request reprint Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
    Y Allanore
    Service de Rhumatologie A, Hopital Cochin, Universite Paris Descartes, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 69:218-21. 2010
    ..To measure the prevalence of, and factors associated with, left ventricular (LV) dysfunction in systemic sclerosis (SSc)...
  18. ncbi request reprint Levels of circulating endothelial progenitor cells in systemic sclerosis
    Y Allanore
    Rheumatology A and Immunology departments, Rene Descartes University, Medical School, Cochin Hospital, Assistance Publique Hopitaux de Paris, France
    Clin Exp Rheumatol 25:60-6. 2007
    ..Our aim was to investigate bone marrow-derived circulating endothelial precursors (EPCs) and activated circulating endothelial cells (CECs) in SSc patients...
  19. doi request reprint N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?
    Y Allanore
    Department of Rheumatology A, Paris Descartes University, Cochin Hospital, APHP, 75014 Paris, France
    Ann Rheum Dis 68:1885-9. 2009
    ..Cardiac involvement, a common and often fatal complication of systemic sclerosis (SSc), is currently detected by standard echocardiography enhanced by tissue Doppler echocardiography (TDE)...
  20. ncbi request reprint Association between an endoglin gene polymorphism and systemic sclerosis-related pulmonary arterial hypertension
    J Wipff
    Rene Descartes University, Medical Faculty, Rheumatology A Department, Cochin Hospital, AP HP, Paris, France
    Rheumatology (Oxford) 46:622-5. 2007
    ..A 6-base insertion in intron 7 (6bINS) of ENG has been reported to be associated with microvascular disturbance...
  21. doi request reprint Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis
    P Dieude
    Universite Paris Diderot, Hopital Bichat Claude Bernard, Paris, France
    Arthritis Rheum 63:1097-105. 2011
    ..The purpose of this study was to test for association of the CD226 rs763361 polymorphism with systemic sclerosis (SSc) in European Caucasian populations...
  22. pmc Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging
    Y Allanore
    Service de Rhumatologie A, Hopital Cochin, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 65:249-52. 2006
    ..Cardiac involvement in idiopathic inflammatory myopathy has been recognised as an important prognostic factor, but treatment remains empirical...
  23. pmc Radiological hand involvement in systemic sclerosis
    J Avouac
    Service de Rhumatologie A, Hopital Cochin, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 65:1088-92. 2006
    ..The osteoarticular and soft tissue structures of the hand may be involved in systemic sclerosis (SSc), causing functional disability...
  24. ncbi request reprint Tetracyclines inhibit nitrosothiol production by cytokine-stimulated osteoarthritic synovial cells
    D Borderie
    Laboratoire de Biochimie A, Hopital Cochin, Paris, France
    Inflamm Res 50:409-14. 2001
    ..To evaluate the capacity of doxycycline and minocycline to inhibit NO production and N-nitrosation reactions in vitro...
  25. doi request reprint Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity
    J Avouac
    Paris Descartes University, Rheumatology A Department, Cochin Hospital, APHP, Paris, France
    Ann Rheum Dis 67:1455-60. 2008
    ..Heterogeneous data have been reported regarding the detection and number of circulating endothelial progenitor cells (EPCs) in systemic sclerosis (SSc)...
  26. ncbi request reprint Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy
    H Lemarechal
    Department of Biochemistry A, Assistance Publique Hopitaux de Paris, Cochin Hospital, 75014 Paris, France
    Clin Chim Acta 372:147-53. 2006
    ..To examine protein oxidation in rheumatoid arthritis (RA) and evaluate its evolution after infliximab therapy in a subgroup of patients...
  27. doi request reprint Evidence of the contribution of the X chromosome to systemic sclerosis susceptibility: association with the functional IRAK1 196Phe/532Ser haplotype
    P Dieude
    Paris Diderot University, AP HP, INSERM U699, Paris, France
    Arthritis Rheum 63:3979-87. 2011
    ..This study was undertaken to test for an association between SSc and the IRAK1 SLE risk haplotype...
  28. doi request reprint Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study
    J Avouac
    Hopital Cochin, Service de Rhumatologie A, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 70:630-3. 2011
    ..To examine the outcomes of hand radiographic x-rays in patients with systemic sclerosis (SSc) and to identify risk factors for the progression of hand radiographic lesions in a prospective cohort...
  29. pmc Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers
    Y Allanore
    Rheumatology A, Paris V University, Assistance Publique Hopitaux de Paris, France
    Ann Rheum Dis 64:481-3. 2005
    ..Increased expression of CD40L has been reported on activated CD4+ T lymphocytes in systemic sclerosis. CD40L can be expressed in soluble form (sCD40L)...
  30. ncbi request reprint Hand vascular involvement assessed by magnetic resonance angiography in systemic sclerosis
    Y Allanore
    Rene Descartes University, and Service de Rheumatologie A, Hopital Cochin, 27 rue du Faubourg St Jacques, 75014 Paris, France
    Arthritis Rheum 56:2747-54. 2007
    ..Magnetic resonance angiography (MRA) has improved the assessment of vascular lesions of the hand. The aim of this study was to evaluate vascular abnormalities in the hands of patients with SSc, using MRA...
  31. doi request reprint Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases
    M Gilson
    Dept of Rheumatology A, Paris Descartes University, Cochin Hospital, Paris, France
    Eur Respir J 35:112-7. 2010
    ..Only diffuse SSc was predictive of a decrease in pulmonary function in this early-SSc cohort. This does not support preliminary data suggestive of a causative role of oesophageal involvement...
  32. pmc Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echocardiography in systemic sclerosis
    O Vignaux
    Services de Radiologie A, Hopital Cochin, AP HP, Universite Paris V, 75014 Paris, France
    Ann Rheum Dis 64:1268-73. 2005
    ..Previous studies have suggested that dihydropyridine-type calcium channel blockers mitigate both myocardial perfusion and function abnormalities...
  33. doi request reprint Outcome measures for heart involvement in systemic sclerosis
    Y Allanore
    Department of Rheumatology A, Paris Descartes University, Cochin Hospital, AP HP, Paris, France
    Rheumatology (Oxford) 47:v51-3. 2008
    ..Their predictive value should also be investigated when there is primary heart involvement...
  34. ncbi request reprint Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury
    N Assous
    Department of Rheumatology A, Paris 5 University, Assistance Publique Hopitaux de Paris, Cochin Hospital, Paris, France
    Clin Exp Rheumatol 23:199-204. 2005
    ..To investigate the prevalence and clinical significance of antiphospholipid antibodies in patients with systemic sclerosis (SSc)...
  35. ncbi request reprint Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients
    J Avouac
    Rene Descartes University, Medical Faculty, Hopital Cochin, France
    Arthritis Rheum 54:2243-9. 2006
    ..To determine the prevalence of sicca symptoms and Sjögren's syndrome (SS) in a 2-center prospective series of patients with systemic sclerosis (SSc), using the American-European Consensus Group criteria for SS...
  36. pmc Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients
    Y Allanore
    Hopital Cochin, Service de Rhumatologie A, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 66:257-9. 2007
    ..Systemic sclerosis (SSc) is characterised by disturbed vessel morphology and an overproduction of vascular endothelial growth factor (VEGF). The VEGF gene located on chromosome 6p21.3 has several polymorphisms...
  37. ncbi request reprint Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells
    Y Allanore
    Department of Rheumatology A, Cochin Hospital, , Paris 75014, France
    Rheumatology (Oxford) 40:1089-96. 2001
    ..Low levels of NO, a vasodilator, may be involved in vasospasm, which is critical in SSc. This may have therapeutic implications...
  38. ncbi request reprint Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials
    J Avouac
    Paris Descartes University, Rheumatology A Department, Cochin Hospital, APHP, Paris, France
    Ann Rheum Dis 67:808-14. 2008
    ....
  39. pmc Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population
    J Wipff
    Rheumatology A Department, Cochin Hospital, Paris, France
    Ann Rheum Dis 65:1230-2. 2006
    ..38). The PTPN22*620W allele was also not associated with autoantibody patterns. Thus, the PTPN22*R620W polymorphism cannot be regarded as a genetic susceptibility factor for SSc in the French Caucasian population...
  40. ncbi request reprint Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases
    C Job-Deslandre
    Service de Rhumatologie A, Hĵpital Cochin, Paris, France
    Joint Bone Spine 68:245-51. 2001
    ..To determine the clinical presentation and outcomes of chronic recurrent multifocal osteomyelitis (CRMO) in pediatric patients...
  41. ncbi request reprint Expression of complement receptors (CR1 and CR3) and Fc gamma RIII on polymorphonuclears from patients with spondylarthropathies
    A Kahan
    INSERM U 283, Cochin Hospital, Paris, France
    Clin Exp Rheumatol 11:27-34. 1993
    ..The results were confirmed by immunoelectroblotting. These findings suggest that membrane and intracellular pools of CR1 and CR3 may contribute to the clinical modulation of the spondylarthropathies...
  42. ncbi request reprint [Spondylarthropathies and anti-TNFalpha drugs]
    S Pavy
    Service de Rhumatologie A, Universite Paris 5, Hopital Cochin, 27, rue du Faubourg Saint Jacques, AP HP, 75014 Paris, France
    Rev Med Interne 26:717-24. 2005
    ..TNFalpha appears as an important actor in the pathogenesis of spondylarthropathies...
  43. ncbi request reprint DHEA in bone and joint diseases
    C Cormier
    Rheumatology Department A, , AP-HP, Paris, France
    Joint Bone Spine 68:588-94. 2001
    ..DHEA cannot be recommended as a treatment for osteoporosis at present given the absence of studies evaluating possible efficacy in reducing the fracture rate and possible long-term side effects...
  44. doi request reprint A descriptive and prognostic study of systemic sclerosis-associated myopathies
    B Ranque
    Universite Paris Descartes, UPRES EA 4058, Department of Internal Medicine, French National Reference Center for Systemic Sclerosis and Necrotizing Vasculitides, Hopital Cochin, Assistance Publique des Hopitaux de Paris, Paris, France
    Ann Rheum Dis 68:1474-7. 2009
    ..To describe the clinical characteristics and muscle pathological features of patients with systemic sclerosis (SSc) and myopathy and analyse their impact on muscle outcome...
  45. doi request reprint [Watermelon stomach in systemic sclerosis]
    K Laoubi
    Service de Rhumatologie A, Hopital Cochin, Universite Paris Descartes, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    J Mal Vasc 35:250-3. 2010
    ..Indeed, specific local treatment must be delivered and is usually efficient despite frequent recurrent events...
  46. doi request reprint NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis
    P Dieude
    Service de Rhumatologie, Paris Diderot University, INSERM U699, Hopital Bichat Claude Bernard, 46 rue Henri Huchard, 75018 Paris, France
    Ann Rheum Dis 70:668-74. 2011
    ..NLRP1 provides a scaffold for the assembly of the inflammasome that promotes the processing and maturation of pro-IL-1β. In addition, NLRP1 variants were found to confer susceptibility to autoimmune disorders...
  47. ncbi request reprint Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism
    E Koumakis
    Department of Rheumatology A, Cochin Hospital, APHP, 27 rue du Faubourg Saint Jacques, 75014, Paris, France
    Osteoporos Int 25:1963-8. 2014
    ..Alkaline phosphatase levels above median were identified as an independent predictor of individual BMD gain in normocalcemic PHPT patients...
  48. ncbi request reprint [Treatment of systemic scleroderma: update]
    Y Allanore
    Service de Rhumatologie A, Universite Paris 5, Faculte de Medecine, Hopital Cochin, Assistance Publique Hopitaux de Paris, 75014 Paris
    Ann Dermatol Venereol 133:286-91. 2006
  49. ncbi request reprint Refractory multicentric reticulohistiocytosis treated by infliximab: two cases
    J Sellam
    Rene Descartes University, Rheumatology A Department, Cochin Hospital, AP HP, Paris, France
    Clin Exp Rheumatol 23:97-9. 2005
    ..A switch to etanercept did not improve polyarthritis in the second patient. Some data suggest that TNFalpha is involved in MRH, but based on our cases anti-TNFalpha therapy needs further evaluation in patients with refractory MRH...
  50. ncbi request reprint N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers
    Y Allanore
    Paris V University, Assistance Publique Hopitaux de Paris, Hopital Cochin, Paris, France
    Arthritis Rheum 48:3503-8. 2003
    ....
  51. ncbi request reprint Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab
    Y Allanore
    Rheumatology A Department, Paris V University, Cochin Hospital, AP HP Paris, France
    Clin Exp Rheumatol 22:756-8. 2004
    ..To investigate autoantibody induction in rheumatoid arthritis (RA) patients treated with infliximab...
  52. ncbi request reprint Postpartal sacral fracture without osteoporosis
    M Rousiere
    Service de Rhumatologie A, H pital Cochin, Paris, France
    Joint Bone Spine 68:71-3. 2001
    ..Rheumatologists should consider sacral fracture in pregnant or nursing patients with buttock pain. Magnetic resonance imaging is the diagnostic investigation of choice...
  53. ncbi request reprint Lack of effect of phenobarbital on ex vivo leukocyte oxidative metabolism in healthy volunteers
    J L Pinquier
    ECLIMED, , , Paris, France
    Fundam Clin Pharmacol 7:311-7. 1993
    ..This study suggests that human polymorphonuclears cytochrome P450 leukotriene B4 omega-hydroxylase and procainamide metabolism is not a useful method to study cytochrome P450 induction in clinical pharmacology...
  54. pmc Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis
    Y Allanore
    Hopital Cochin, Service de Rhumatologie A, 27 rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Rheum Dis 63:1276-8. 2004
    ..Cardiovascular diseases, vasospasm, and dysimmunity have been implicated in normal tension glaucoma (NTG)...
  55. ncbi request reprint 169Erbium-citrate synoviorthesis after failure of local corticosteroid injections to treat rheumatoid arthritis-affected finger joints
    A Kahan
    Paris V University, Rheumatology A Department, Hopital Cochin, AP HP, Paris, France
    Clin Exp Rheumatol 22:722-6. 2004
    ..However, its efficacy in corticosteroid-resistant rheumatoid arthritis-affected joints has not been clearly demonstrated...
  56. ncbi request reprint Prevalence of Barrett's esophagus in systemic sclerosis
    J Wipff
    Cochin Hospital, AP HP Paris 5 University, Paris, France
    Arthritis Rheum 52:2882-8. 2005
    ..This study sought to determine the prevalence of BE and esophageal adenocarcinoma in a cohort of SSc patients...
  57. ncbi request reprint [Hyperparathyroidism and osteoporosis]
    C Cormier
    Service de Rhumatologie A, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Rev Med Interne 25:S560-7. 2004
    ..Parathyroid hormone assays are being increasingly performed as part of the routine evaluation of osteoporosis...
  58. ncbi request reprint Brachial plexopathy associated with systemic sclerosis
    Y Allanore
    Cochin Hospital, Assistance Publique Hopitaux de Paris, Rene Descartes University, France
    Clin Rheumatol 21:401-2. 2002
    ..We report a third case of brachial plexopathy, presumably related to vasculitis, in a patient with systemic sclerosis, which improved after cyclophosphamide therapy...
  59. ncbi request reprint Sacral inflammatory pseudotumor revealed by paraneoplastic syndrome
    Y Allanore
    Department of Rheumatology, Assistance Publique Hopitaux de Paris, Rene Descartes University, Paris, France
    Rheumatol Int 24:166-8. 2004
    ..All clinical symptoms disappeared within a few days after surgery, which is suggestive of a paraneoplastic syndrome. No relapse has occurred after 4 years...
  60. ncbi request reprint Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis
    P de Groote
    Hopital Cardiologique, Service de Cardiologie C, Boulevard du Professeur Leclercq, CHRU, 59037 Lille Cedex, France
    Ann Rheum Dis 67:31-6. 2008
    ..However, previous studies have generally been conducted in small populations. The aims of this study were to prospectively screen for PAH and to describe echocardiographic parameters in a large group of SSc patients...
  61. ncbi request reprint [Myocardial microvascularization in scleroderma]
    A Kahan
    Service de Rhumatologie, , Paris
    Arch Mal Coeur Vaiss 81:495-500. 1988
    ..Finally, the preliminary results of long-term studies suggest that some coronary vasodilators may be beneficial in the long-term treatment of myocardial perfusion abnormalities in systemic sclerosis...
  62. ncbi request reprint Progressive osseous heteroplasia: a rare case of late onset
    R Seror
    Rheumatology (Oxford) 46:716-7. 2007
  63. ncbi request reprint Predominant primitive right ventricular involvement in systemic sclerosis
    C Meune
    Clin Exp Rheumatol 25:658. 2007
  64. doi request reprint Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
    Josef S Smolen
    Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
    Lancet 371:987-97. 2008
    ..Our aim was to assess the therapeutic effects of blocking interleukin 6 by inhibition of the interleukin-6 receptor with tocilizumab in patients with rheumatoid arthritis...
  65. pmc Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab
    Y Allanore
    Ann Rheum Dis 65:834-5. 2006
  66. ncbi request reprint [Inducible nitric oxide synthase expression and nitric oxide production by monocytes in systemic sclerosis]
    C J Menkes
    Service de Rhumatologie A, Hopital Cochin, 27 rue du Faubourg Saint Jacques 75679 Paris
    Bull Acad Natl Med 185:509-22; discussion 522-3. 2001
    ..Low levels of NO, a vasodilator, may be involved in vasospasm, which is critical in SSc. This may suggest therapeutic implications...
  67. ncbi request reprint Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis
    R D Altman
    Rheumatology and Immunology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Osteoarthritis Cartilage 13:13-9. 2005
    ....
  68. ncbi request reprint [Pulmonary arterial hypertension in systemic sclerosis: definition of a screening algorithm for early detection (the ItinérAIR-Sclérodermie Study)]
    E Hachulla
    Service de Medecine Interne, CHRU Claude Huriez, Place de Verdun, 59037 Lille Cedex, France
    Rev Med Interne 25:340-7. 2004
    ..Its prevalence varies from 5% to 35% in the literature. A systematic yearly screening is recommended for early detection and management of PAH, but no precise algorithm is yet available...
  69. ncbi request reprint Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice: an open label observational study
    N Assous
    Clin Exp Rheumatol 25:504. 2007